Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Intravitreal JSM-6427 well tolerated in age-related macular degeneration patients

April 8, 2008

ISTA reports results from clinical trial of once-daily Xibrom for ocular inflammation

April 4, 2008

Recent Merck & Co. patent discloses new remedial options for glaucoma

April 4, 2008

ThromboGenics completes patient enrollment in phase IIb MIVI III trial of microplasmin

April 3, 2008

MethylGene enters agreement with Otsuka for small-molecule kinase inhibitors

April 1, 2008

Recent Allergan patent divulges novel antiglaucoma agents

March 28, 2008

Novel alphav integrin inhibitor profiled at Johnson & Johnson

March 26, 2008

Alimera and pSivida amend license and collaboration agreement for Medidur FA

March 20, 2008

Oxigene plans to file an IND for Zybrestat based on positive results in primates

March 14, 2008

iCo Therapeutics presents a clinical update on human monoclonal antibody iCo-008

March 13, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...